| 000 | 01806 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250514011003.0 | ||
| 264 | 0 | _c20011101 | |
| 008 | 200111s 0 0 eng d | ||
| 022 | _a0022-538X | ||
| 024 | 7 |
_a10.1128/JVI.75.20.9644-9653.2001 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPeters, S | |
| 245 | 0 | 0 |
_aResistance to nucleoside analog reverse transcriptase inhibitors mediated by human immunodeficiency virus type 1 p6 protein. _h[electronic resource] |
| 260 |
_bJournal of virology _cOct 2001 |
||
| 300 |
_a9644-53 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAmino Acid Sequence |
| 650 | 0 | 4 |
_aAnti-HIV Agents _xtherapeutic use |
| 650 | 0 | 4 | _aBase Sequence |
| 650 | 0 | 4 | _aCloning, Molecular |
| 650 | 0 | 4 |
_aDrug Resistance, Microbial _xgenetics |
| 650 | 0 | 4 |
_aGene Products, gag _xbiosynthesis |
| 650 | 0 | 4 | _aGenes, Viral |
| 650 | 0 | 4 |
_aHIV Infections _xdrug therapy |
| 650 | 0 | 4 |
_aHIV-1 _xchemistry |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMolecular Sequence Data |
| 650 | 0 | 4 | _aMutagenesis, Site-Directed |
| 650 | 0 | 4 | _aPolymorphism, Genetic |
| 650 | 0 | 4 |
_aProline _xgenetics |
| 650 | 0 | 4 |
_aReverse Transcriptase Inhibitors _xtherapeutic use |
| 650 | 0 | 4 |
_aViral Proteins _xbiosynthesis |
| 650 | 0 | 4 | _agag Gene Products, Human Immunodeficiency Virus |
| 700 | 1 | _aMuñoz, M | |
| 700 | 1 | _aYerly, S | |
| 700 | 1 | _aSanchez-Merino, V | |
| 700 | 1 | _aLopez-Galindez, C | |
| 700 | 1 | _aPerrin, L | |
| 700 | 1 | _aLarder, B | |
| 700 | 1 | _aCmarko, D | |
| 700 | 1 | _aFakan, S | |
| 700 | 1 | _aMeylan, P | |
| 700 | 1 | _aTelenti, A | |
| 773 | 0 |
_tJournal of virology _gvol. 75 _gno. 20 _gp. 9644-53 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1128/JVI.75.20.9644-9653.2001 _zAvailable from publisher's website |
| 999 |
_c11481925 _d11481925 |
||